Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. (Q48440308)

11 February 2018

title

Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. (English)

1 reference

11 February 2018

1 reference

Duplex ultrasonography

1 reference

Damien Logeart

1

1 reference

11 February 2018

Carole Saudubray

2

1 reference

11 February 2018

Pascale Beyne

3

1 reference

11 February 2018

Gabriel Thabut

4

1 reference

11 February 2018

Pierre-Vladimir Ennezat

5

1 reference

11 February 2018

Christophe Chavelas

6

1 reference

11 February 2018

Caroline Zanker

7

1 reference

11 February 2018

Erik Bouvier

8

1 reference

11 February 2018

Alain Cohen Solal

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 November 2002

1 reference

11 February 2018

Journal of the American College of Cardiology

published in

1 reference

11 February 2018

volume

40

1 reference

11 February 2018

issue

10

1 reference

11 February 2018

page(s)

1794-1800

1 reference

11 February 2018

Validity of clinical diagnosis of heart failure in primary health care

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Plasma brain natriuretic peptide in assessment of acute dyspnoea.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta Stone

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

The echo-Doppler evaluation of left ventricular diastolic function. A current perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Natriuretic peptides--relevance in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

New Doppler echocardiographic applications for the study of diastolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

New insights into diastolic dysfunction as the cause of acute left-sided heart failure associated with systemic hypertension and/or coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

A personal ultrasound imager (ultrasound stethoscope). A revolution in the physical cardiac diagnosis!

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902482-8

7 January 2021

10.1016/S0735-1097(02)02482-8

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

12446063

1 reference

11 February 2018